 | Up a level |
2021
Beyer, Jorg, Collette, Laurence 
ORCID: 0000-0003-2518-7281, Sauve, Nicolas, Daugaard, Gedske ORCID: 0000-0002-9618-9180, Feldman, Darren R., Tandstad, Torgrim, Tryakin, Alexey ORCID: 0000-0003-2245-214X, Stahl, Olof, Gonzalez-Billalabeitia, Enrique, De Giorgi, Ugo, Culine, Stephane, de Wit, Ronald, Hansen, Aaron R., Bebek, Marko, Terbuch, Angelika ORCID: 0000-0003-2918-1370, Albany, Costantine, Hentrich, Marcus, Gietema, Jourik A., Negaard, Helene, Huddart, Robert A., Lorch, Anja, Cafferty, Fay H., Heng, Daniel Y. C., Sweeney, Christopher J., Winquist, Eric, Chovanec, Michal, Fankhauser, Christian, Stark, Daniel, Grimison, Peter, Necchi, Andrea, Tran, Ben, Heidenreich, Axel, Shamash, Jonathan, Sternberg, Cora N., Vaughn, David J., Duran, Ignacio, Bokemeyer, Carsten, Patrikidou, Anna, Cathomas, Richard, Assele, Samson and Gillessen, Silke ORCID: 0000-0001-5746-6555
(2021).
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J. Clin. Oncol., 39 (14).
S. 1553 - 1569.
PHILADELPHIA:
LIPPINCOTT WILLIAMS & WILKINS.
ISSN 1527-7755
Butt, Sabeeh-ur-Rehman, Mejias, Alberto, Morelli, Cristina, Torga, Gonzalo, Happe, Marlene, Patrikidou, Anna and Arkenau, Hendrik-Tobias (2021). BRAF/MEK inhibitors for BRAF V600E-mutant cancers in non-approved setting: a case series. Cancer Chemother. Pharmacol., 87 (3). S. 437 - 442. NEW YORK: SPRINGER. ISSN 1432-0843